Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults-Reference-Cited by-同舟云学术

Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults

Published:2024-02-06 Issue:2 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Caulley Lisa¹²³⁴,Quinn Jason G⁵,Doyle Mary-Anne²⁶,Alkherayf Fahad²⁷,Metzendorf Maria-Inti⁸,Kilty Shaun¹²,Hunink M G Myriam⁹¹⁰

Affiliation:

1. Department of Otolaryngology - Head and Neck Surgery; University of Ottawa; Ottawa Canada

2. Clinical Epidemiology Program; Ottawa Hospital Research Institute; Ottawa Canada

3. Department of Epidemiology; Erasmus University Medical Center Rotterdam; Rotterdam Netherlands

4. Institut for Klinisk Medicin; Aarhus University; Aarhus Denmark

5. Department of Pathology and Laboratory Medicine; Dalhousie University; Halifax Canada

6. Endocrinology and Metabolism; University of Ottawa; Ottawa Canada

7. Department of Neurosurgery; University of Ottawa; Ottawa Canada

8. Institute of General Practice; Medical Faculty of the Heinrich-Heine University; Düsseldorf Germany

9. Department of Epidemiology and Biostatistics and Department of Radiology and Nuclear Medicine; Erasmus University Medical Center Rotterdam; Rotterdam Netherlands

10. Center for Health Decision Sciences; Harvard T.H. Chan School of Public Health, Boston; Boston Massachussetts USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference188 articles.

1. Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma;Cannavo;Hormone and Metabolic Research,2001

2. Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study;Colao;Clinical Endocrinology,2009

3. Fahlbusch R Kleinberg D Biller B Bonert V Buchfelder M Cappabianca P Surgical debulking of pituitary adenomas improves responsiveness to octreotide LAR in the treatment of acromegaly Pituitary 2017 20 6 668 75

4. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial;Carlsen;Journal of Clinical Endocrinology and Metabolism,2008

5. Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial;Fougner;European Journal of Endocrinology,2014